Investigates non-esterified fatty acid levels during hemodialysis, suggesting new management strategies.
Background : Although increases in plasma levels of non-esterified fatty acids (NEFA) during hemodialysis (HD) have been reported, the precise time course of this elevation, its underlying pathophysiology, and effective therapeutic strategies remain unclear.
No takes yet. Share an insight, caveat, or question.
Fujiwara et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: